Mirum Pharmaceuticals, Inc. MIRM Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Mirum Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s earnings yield?
- Mirum Pharmaceuticals, Inc. (MIRM) reported earnings yield of -14.3% in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s earnings yield changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s earnings yield decreased by 309.1% year-over-year, from -3.5% to -14.3%.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s earnings yield?
- Over 4 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s earnings yield has grown at a -58.5% compound annual growth rate (CAGR), from -19.3% to -0.6%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.